Glycolipid derivative
    3.
    发明授权
    Glycolipid derivative 有权
    糖脂衍生物

    公开(公告)号:US06635622B2

    公开(公告)日:2003-10-21

    申请号:US09878425

    申请日:2001-06-12

    IPC分类号: A61K3170

    摘要: The present invention is a compound of general formula (I) or a pharmaceutically acceptable salt of, wherein W represents carbon chain from 9 to 17 which containing double bond or hydroxy group occasionally; X represents carbon chain from 11 to 25 which containing double bond or hydroxy group occasionally; Y represents —(CH2)a—CH═CH—(CH2)a′—, —(CH2)a— (a, a′ denotes an integer of 0-5 and a+a′ is 5 and under.), —S(O)0-2CH2—, —NHCH2—; Z represents —CO—, —SO2—; R represents —CH2OH, CO2H, CH2OCH2CO2SO3H; R0 represents —OH, —NH2, —NHAc.

    摘要翻译: 本发明是通式(I)的化合物或其药学上可接受的盐,其中W代表偶氮含有双键或羟基的9至17的碳链; X表示偶尔含有双键或羟基的碳数为11〜25的碳链; Y表示 - (CH 2)a -CH = CH-(CH 2)a - , - (CH 2)a - (a,a'表示0-5的整数,a + a'为5以下) S(O)0-2CH 2 - , - NHCH 2 - ; Z表示-CO-,-SO 2 - ; R表示-CH 2 OH,CO 2 H,CH 2 OCH 2 CO 2 SO 3 H; R 0表示-OH,-NH 2,-NHAc。

    C-glycosides and preparation of thereof as antidiabetic agents
    4.
    发明授权
    C-glycosides and preparation of thereof as antidiabetic agents 有权
    C-糖苷及其作为抗糖尿病药的制剂

    公开(公告)号:US06627611B2

    公开(公告)日:2003-09-30

    申请号:US09766600

    申请日:2001-01-23

    IPC分类号: A61K3170

    摘要: C-glycoside derivatives are disclosed, which are represented by the following formula (I) and its pharmaceutical acceptable salt, and which are useful for the treatment and/or prevention of diabetes and hypoglycemia. wherein: with the provisos that R1 is H, OH, lower alkyl, O-lower alkyl or R2 is H, —COO-lower alkyl, R5 is —CH2OH, —CH2OCO2-lower alkyl, —CH2OSO3H, —COOH or —COONa; wherein: A is (with the provisos that X is oxygen atom, nitrogen atom or sulfur atom R3 is lower alkyl when m=0, and is lower alkyl, —OH or —O-lower alkyl when m=1, . . . means saturated or unsaturated carbon bond; m is 0 or 1; n is 0, 1 or 2; above mentioned-lower alkyl means C1-C5.) or a pharmaceutical acceptable salt.

    摘要翻译: 公开了由下式(I)表示的C-糖苷衍生物及其药学上可接受的盐,其可用于治疗和/或预防糖尿病和低血糖。其中:条件是R 1是H,OH, 低级烷基,O-低级烷基或R 2为H,-COO-低级烷基,R 5为-CH 2 OH,-CH 2 OCO 2 - 低级烷基,-CH 2 OSO 3 H,-COOH或-COONa;其中:A为(条件是X为氧原子 当m = 0时,氮原子或硫原子R 3为低级烷基,m = 1时为低级烷基,-OH或-O-低级烷基,表示饱和或不饱和碳键; m为0或1; n为 0,1或2;上述低级烷基手段C1-C5)或药学上可接受的盐。

    Thiazole derivatives and procedure of synthesis thereof
    10.
    发明授权
    Thiazole derivatives and procedure of synthesis thereof 失效
    噻唑衍生物及其合成方法

    公开(公告)号:US4578478A

    公开(公告)日:1986-03-25

    申请号:US553183

    申请日:1983-11-18

    申请人: Tsuyoshi Tomiyama

    发明人: Tsuyoshi Tomiyama

    CPC分类号: C07D277/38

    摘要: A series of new 2,4-substituted thiazole derivatives are disclosed. These compounds have anti-histaminergic activity, especially, outstanding gastric anti-secretory activity.The compounds of this invention are obtained mainly by reacting 2-substituted-4-aminoalkyl-thiomethyl thiazole with a compound having methylthio or hydroxy group corresponding thereto.

    摘要翻译: 公开了一系列新的2,4-取代噻唑衍生物。 这些化合物具有抗组胺能活性,特别是出色的胃反分泌活性。 本发明化合物主要通过2-取代-4-氨基烷基硫代甲基噻唑与对应有甲硫基或羟基的化合物反应而得到。